NewsRoom Articles - Page 1081 of 1256

WednesdayJun 21, 2017 1:16 pm

Crexendo’s (CXDO) Revolutionary Cloud-Based Phone Systems Let Businesses ‘Cut the Cord’ Between Offices and the Outside World

Offering high-quality voice, data, and marketing solutions that help businesses focus on their core operations, Crexendo, Inc. (OTCQX: CXDO) is a competitive local exchange carrier (CLEC) cloud services company that offers award-winning cloud telecommunications, broadband Internet, and other cloud business services. The company provides critical voice and data technology infrastructure for startups, small and medium-sized business (SMB), and small enterprise markets, offering enterprise-caliber cloud services at affordable monthly rates. The company’s world-class services help businesses significantly increase their productivity, and Crexendo is payment card industry-compliant and CLEC-licensed for its cloud web, telecommunications, and network services. Guided by a team of…

WednesdayJun 21, 2017 9:46 am

Algae Dynamics Corp. (ADYNF) is “One to Watch”

Algae Dynamics Corp (OTCQB: ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae. The original core of the company’s product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives…

TuesdayJun 20, 2017 3:53 pm

InMed Pharmaceuticals, Inc. (IMLFF) is a Player in the Billion Dollar Cannabis Biotech Market

Despite the fire-breathing from Attorney-General Jefferson Beauregard Sessions III, there is a distinct feeling that marijuana has entered the mainstream now that Goldman Sachs has initiated coverage on GW Pharma (NASDAQ: GWPH). GW Pharma is the biopharmaceutical that developed the cannabinoid-derived Sativex to treat spasticity due to multiple sclerosis (MS), now approved by regulatory authorities in 29 countries. The success of GW Pharma and other pharmaceutical companies focused on cannabinoid research has produced an exciting new field with a lot of promise, cannabis biotech, and InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is staking a position in that emerging market.…

TuesdayJun 20, 2017 3:06 pm

Net Element, Inc. (NASDAQ: NETE) on Pace to Record Revenues of $75 Million by 2018, per Zacks Research Report

Net Element, Inc. (NASDAQ: NETE) is seen reaching revenues of $75 million in 2018 by a Zacks Research Report issued in May 2017 (http://nnw.fm/wV8IN). In the Zacks Small-Cap Research Report, it is estimated that the company’s sales will reach $63 million in 2017 and $74.6 million in 2018. Net Element reported actual revenues of $54.3 million in 2016. Net Element is a high technology financial group that digitally processes transactions in an omni-channel environment in what is becoming a world of cashless transactions. It processes the electronic transactions from both point-of-sale and mobile devices. Driving this forecast revenue growth is…

TuesdayJun 20, 2017 9:58 am

Moxian, Inc. (NASDAQ: MOXC) Leveraging High Gross Margin and Existing SME Customer Base in China’s O2O Market

Moxian, Inc. (NASDAQ: MOXC) offers investors a high risk-high reward opportunity in China’s online-to-offline (O2O) marketplace, and the key is the high gross margin percentages of the company’s revenues, according to the SeeThruEquity (http://nnw.fm/dee5W) research report on the company. Shenzhen, China-based Moxian has a gross margin of 77.4% — second-highest of all of its significantly higher market cap competitors, the report says. MOXC is a development stage company that's currently executing its marketing strategy of converting its two O2O platforms from unpaid to paid. Moxian+ is a business platform which is already serving, at no charge, some 30,000 small market…

MondayJun 19, 2017 2:41 pm

InMed Pharmaceuticals, Inc. (IMLFF) Gains Attention for Its Operational Developments and Leadership Team

InMed Pharmaceuticals, Inc. (OTCQB: IMLFF), a pre-clinical stage biopharmaceutical company that specializes in the development of therapies through research and development into the pharmacology of cannabinoids and drug delivery systems, continues to get positive media coverage of ongoing operational developments, propelled by the company’s impressive leadership team. Insider Financial highlighted InMed Pharmaceuticals as a “Cannabis Runner” in an article back in January, stating that “This is the kind of company that needs to maintain a positive news flow in order to keep investors interested.” More recently, Forbes released an article describing the company as “more than just another cannabis drug…

MondayJun 19, 2017 11:11 am

Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) Steps Up Exploration to Help Solve Global Zinc Shortage

With demand constantly on the rise and the recent closing of several mining operations in China, the global shortage of zinc has grown exponentially. The zinc shortage is expected to widen to 360,000 tons this year (http://nnw.fm/wp6L4), according to market analysts, but the figure might grow further in wake of China’s decision to completely halt production as part of a nationwide environmental crackdown on the local steel industry. Major zinc exploration projects such as Canadian mining company Kootenay Zinc Corp.’s (CSE: ZNK) (OTCQB: KTNNF) Sully property could have a major impact on the global output of zinc and significantly narrow…

MondayJun 19, 2017 9:16 am

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) Detection Technology to Protect the Public

Nowhere seems safe anymore in a world filled with evildoers, the mentally deranged, radical religious extremists, or anyone with criminal intent. One of the latest acts of heinous depredation killed 22 and injured 166 in a suicide bombing at Manchester Arena — kids, mostly young girls, out for a night of revelry at an Ariana Grande concert. Lives destroyed and dreams demolished in split seconds of stark terror. Civilized society and grieving families worldwide beg for answers and protection from the insanity. Public places, venues and events are nearly impossible to secure. So called soft targets have become targets of…

MondayJun 19, 2017 8:51 am

Nasdaq and Bats Square off on Market-Close Orders

The status quo never likes change, nor the upstarts that attempt to initiate innovation. When innovation and change occur, the entrenched typically lose prominence, certainly preeminence, and often times money. Disagreement and conflict ensue, but the strongest survive and seem to stay in power. It happens across the full spectrum of businesses, and it’s happening again now with Nasdaq, Inc. and Bats Global Markets. Most are familiar with Nasdaq, the world's first electronic stock market. It was founded in 1971 by the National Association of Securities Dealers, the financial self-regulatory agency of its era. At first, Nasdaq was only a…

FridayJun 16, 2017 12:00 pm

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Starts Presentation at the 2017 Marcum Microcap Conference

Tonix Pharmaceuticals (NASDAQ: TNXP) is developing innovative pharmaceutical products to address major public health challenges. In addition to TNX-102 SL for PTSD, Tonix is developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (Investigational New Drug) application stage, designed as a daytime treatment for PTSD and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage, as a potential smallpox-preventing vaccine. Company executives have a track record of success in drug development, regulatory approvals, and product launch activities. For more information, visit the company's website at www.tonixpharma.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides…

Financial news and publishing for public and private companies

Contact us: 212.418.1217